| 2GF7 |
2.2 |
Double tudor domain structure |
| 2GFA |
2.1 |
double tudor domain complex structure |
| 2GP3 |
2.35 |
Crystal structure of the catalytic core domain of jmjd2a |
| 2GP5 |
2.28 |
Crystal structure of catalytic core domain of jmjd2A complexed with alpha-Ketoglutarate |
| 2OQ6 |
2.0 |
Crystal structure of JMJD2A complexed with histone H3 peptide trimethylated at Lys9 |
| 2OQ7 |
2.15 |
The crystal structure of JMJD2A complexed with Ni and N-oxalylglycine |
| 2OS2 |
2.3 |
Crystal structure of JMJD2A complexed with histone H3 peptide trimethylated at Lys36 |
| 2OT7 |
2.135 |
Crystal structure of JMJD2A complexed with histone H3 peptide monomethylated at Lys9 |
| 2OX0 |
1.95 |
Crystal structure of JMJD2A complexed with histone H3 peptide dimethylated at Lys9 |
| 2P5B |
1.99 |
The complex structure of JMJD2A and trimethylated H3K36 peptide |
| 2PXJ |
2.0 |
The complex structure of JMJD2A and monomethylated H3K36 peptide |
| 2Q8C |
2.047 |
Crystal structure of JMJD2A in ternary complex with an histone H3K9me3 peptide and 2-oxoglutarate |
| 2Q8D |
2.29 |
Crystal structure of JMJ2D2A in ternary complex with histone H3-K36me2 and succinate |
| 2Q8E |
2.05 |
Specificity and Mechanism of JMJD2A, a Trimethyllysine-Specific Histone Demethylase |
| 2QQR |
1.8 |
JMJD2A hybrid tudor domains |
| 2QQS |
2.82 |
JMJD2A tandem tudor domains in complex with a trimethylated histone H4-K20 peptide |
| 2VD7 |
2.25 |
Crystal Structure of JMJD2A complexed with inhibitor Pyridine-2,4- dicarboxylic acid |
| 2WWJ |
2.6 |
STRUCTURE OF JMJD2A COMPLEXED WITH INHIBITOR 10A |
| 2YBK |
2.4 |
JMJD2A COMPLEXED WITH R-2-HYDROXYGLUTARATE |
| 2YBP |
2.02 |
JMJD2A COMPLEXED WITH R-2-HYDROXYGLUTARATE AND HISTONE H3K36me3 PEPTIDE (30-41) |
| 2YBS |
2.32 |
JMJD2A COMPLEXED WITH S-2-HYDROXYGLUTARATE AND HISTONE H3K36me3 PEPTIDE (30-41) |
| 3NJY |
2.6 |
Crystal structure of JMJD2A complexed with 5-carboxy-8-hydroxyquinoline |
| 3PDQ |
1.989 |
Crystal structure of JMJD2A complexed with bipyridyl inhibitor |
| 3RVH |
2.251 |
Crystal Structure of JMJD2A Complexed with Inhibitor |
| 3U4S |
2.15 |
Histone Lysine demethylase JMJD2A in complex with T11C peptide substrate crosslinked to N-oxalyl-D-cysteine |
| 4AI9 |
2.25 |
JMJD2A Complexed with Daminozide |
| 4BIS |
2.493 |
JMJD2A COMPLEXED WITH 8-HYDROXYQUINOLINE-4-CARBOXYLIC ACID |
| 4GD4 |
2.33 |
Crystal Structure of JMJD2A Complexed with Inhibitor |
| 4URA |
2.23 |
Crystal structure of human JMJD2A in complex with compound 14a |
| 4V2V |
2.0 |
JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H3K27me3 PEPTIDE (25-29) ARK(me3)SA |
| 4V2W |
1.81 |
JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H3K27me3 PEPTIDE (16-35) |
| 5A7N |
2.39 |
Crystal structure of human JMJD2A in complex with compound 43 |
| 5A7O |
2.15 |
Crystal structure of human JMJD2A in complex with compound 42 |
| 5A7P |
2.28 |
Crystal structure of human JMJD2A in complex with compound 36 |
| 5A7Q |
2.0 |
Crystal structure of human JMJD2A in complex with compound 30 |
| 5A7S |
2.2 |
Crystal structure of human JMJD2A in complex with compound 44 |
| 5A7W |
2.27 |
Crystal structure of human JMJD2A in complex with compound 35 |
| 5A80 |
2.28 |
Crystal structure of human JMJD2A in complex with compound 40 |
| 5ANQ |
2.0 |
inhibitors of JumonjiC domain-containing histone demethylases |
| 5D6W |
1.992 |
Crystal structure of double tudor domain of human lysine demethylase KDM4A |
| 5D6X |
2.153 |
Crystal structure of double tudor domain of human lysine demethylase KDM4A |
| 5D6Y |
2.287 |
Crystal structure of double tudor domain of human lysine demethylase KDM4A complexed with histone H3K23me3 |
| 5F2S |
2.08 |
Crystal structure of human KDM4A in complex with compound 15 |
| 5F2W |
2.6 |
Crystal structure of human KDM4A in complex with compound 16 |
| 5F32 |
2.05 |
Crystal structure of human KDM4A in complex with compound 40 |
| 5F37 |
2.22 |
Crystal structure of human KDM4A in complex with compound 58 |
| 5F39 |
2.65 |
Crystal structure of human KDM4A in complex with compound 37 |
| 5F3C |
2.06 |
Crystal structure of human KDM4A in complex with compound 52d |
| 5F3E |
2.16 |
Crystal structure of human KDM4A in complex with compound 54a |
| 5F3G |
2.5 |
Crystal structure of human KDM4A in complex with compound 53a |
| 5F3I |
2.24 |
Crystal structure of human KDM4A in complex with compound 54j |
| 5F5I |
2.63 |
Crystal Structure of human JMJD2A complexed with KDOOA011340 |
| 5FPV |
2.44 |
Crystal structure of human JMJD2A in complex with compound KDOAM20A |
| 5FWE |
2.05 |
JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H4(1-15)R3me2s PEPTIDE |
| 5FY8 |
2.343 |
Crystal structure of human JMJD2A in complex with D-threo-isocitrate |
| 5FYC |
2.261 |
Crystal structure of human JMJD2A in complex with succinate |
| 5FYH |
2.348 |
Crystal structure of human JMJD2A in complex with fumarate |
| 5FYI |
2.096 |
Crystal structure of human JMJD2A in complex with pyruvate |
| 5LY1 |
2.5 |
JMJD2A/ KDM4A COMPLEXED WITH NI(II) AND Macrocyclic PEPTIDE Inhibitor CP2 (13-mer) |
| 5LY2 |
2.43 |
JMJD2A/ KDM4A COMPLEXED WITH NI(II), NOG AND Macrocyclic PEPTIDE Inhibitor CP2_R6Kme3 (13-mer) |
| 5TVR |
2.093 |
JMJD2A in complex with Ni(II) and alpha-Ketoglutarate |
| 5TVS |
2.745 |
JMJD2A in complex with Ni(II) |
| 5VAR |
1.83 |
Crystal structure of KDM4A tandem TUDOR domain in complex with a tri-methyl lysine competitive inhibitor |
| 5VGI |
2.07 |
Crystal Structure of KDM4 with the Small Molecule Inhibitor QC6352 |
| 5VMP |
2.48 |
Crystal Structure of Human KDM4 with Small Molecule Inhibitor QC5714 |
| 6CG1 |
2.16 |
Crystal Structure of KDM4A with Compound 14 |
| 6CG2 |
2.34 |
Crystal Structure of KDM4A with Compound 8 |
| 6G5W |
1.83 |
Crystal Structure of KDM4A with compound YP-03-038 |
| 6G5X |
1.78 |
Crystal Structure of KDM4A with compound YP-02-145 |
| 6H4O |
2.25 |
Crystal structure of human KDM4A in complex with compound 18a |
| 6H4P |
2.19 |
Crystal structure of human KDM4A in complex with compound 16a |
| 6H4Q |
2.31 |
Crystal structure of human KDM4A in complex with compound 34a |
| 6H4R |
2.14 |
Crystal structure of human KDM4A in complex with compound 17f |
| 6H4S |
2.45 |
Crystal structure of human KDM4A in complex with compound 16m |
| 6H4T |
2.38 |
Crystal structure of human KDM4A in complex with compound 19a |
| 6H4U |
2.21 |
Crystal structure of human KDM4A in complex with compound 34b |
| 6H4V |
2.15 |
Crystal structure of human KDM4A in complex with compound 34g |
| 6H4W |
2.81 |
Crystal structure of human KDM4A in complex with compound 19d |
| 6H4X |
2.34 |
Crystal structure of human KDM4A in complex with compound 17b |
| 6H4Y |
2.38 |
Crystal structure of human KDM4A in complex with compound 17e |
| 6H8P |
1.983 |
JMJD2A/ KDM4A COMPLEXED WITH NI(II), NOG AND Histone H1.4(18-32)K26me3 peptide (15-mer) |
| 6HGT |
2.33 |
Crystal structure of human KDM4A complexed with co-substrate analog NOG and histone H3 peptide with K9R mutation |
| 7D4A |
2.201 |
The Crystal Structure of human JMJD2A Tudor domain from Biortus |
| 7EQV |
2.6 |
Crystal structure of JMJD2A complexed with 3,4-dihydroxybenzoic acid |
